%0 Journal Article
%T Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers.
%A Asmundo L
%A Rizzetto F
%A Blake M
%A Anderson M
%A Mojtahed A
%A Bradley W
%A Shenoy-Bhangle A
%A Fernandez-Del Castillo C
%A Qadan M
%A Ferrone C
%A Clark J
%A Ambrosini V
%A Picchio M
%A Mapelli P
%A Evangelista L
%A Leithner D
%A Nikolaou K
%A Ursprung S
%A Fanti S
%A Vanzulli A
%A Catalano OA
%J J Clin Med
%V 13
%N 11
%D 2024 Jun 2
%M 38892992
%F 4.964
%R 10.3390/jcm13113281
%X Neuroendocrine neoplasms (NENs) are a diverse group of tumors with varying clinical behaviors. Their incidence has risen due to increased awareness, improved diagnostics, and aging populations. The 2019 World Health Organization classification emphasizes integrating radiology and histopathology to characterize NENs and create personalized treatment plans. Imaging methods like CT, MRI, and PET/CT are crucial for detection, staging, treatment planning, and monitoring, but each of them poses different interpretative challenges and none are immune to pitfalls. Treatment options include surgery, targeted therapies, and chemotherapy, based on the tumor type, stage, and patient-specific factors. This review aims to provide insights into the latest developments and challenges in NEN imaging, diagnosis, and management.